| Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated MD Chuong, GM Springett, JM Freilich, CK Park, JM Weber, EA Mellon, ... International Journal of Radiation Oncology* Biology* Physics 86 (3), 516-522, 2013 | 392 | 2013 |
| First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE … HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ... The Lancet Oncology 18 (9), 1159-1171, 2017 | 369 | 2017 |
| Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient PW Sperduto, S Mesko, J Li, D Cagney, A Aizer, NU Lin, E Nesbit, ... Journal of clinical oncology 38 (32), 3773, 2020 | 273 | 2020 |
| Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma EA Mellon, SE Hoffe, GM Springett, JM Frakes, TJ Strom, PJ Hodul, ... Acta oncologica 54 (7), 979-985, 2015 | 246 | 2015 |
| Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline … MHG Katz, FS Ou, JM Herman, SA Ahmad, B Wolpin, R Marsh, S Behr, ... BMC cancer 17, 1-8, 2017 | 145 | 2017 |
| Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 phase 2 randomized … MHG Katz, Q Shi, J Meyers, JM Herman, M Chuong, BM Wolpin, S Ahmad, ... JAMA oncology 8 (9), 1263-1270, 2022 | 128 | 2022 |
| Ablative 5-fraction stereotactic magnetic resonance–guided radiation therapy with on-table adaptive replanning and elective nodal irradiation for inoperable pancreas cancer MD Chuong, J Bryant, KE Mittauer, M Hall, R Kotecha, D Alvarez, ... Practical radiation oncology 11 (2), 134-147, 2021 | 127 | 2021 |
| Radiation therapy and esophageal cancer R Shridhar, K Almhanna, KL Meredith, MC Biagioli, MD Chuong, A Cruz, ... Cancer Control 20 (2), 97-110, 2013 | 118 | 2013 |
| Intensity-modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal MD Chuong, JM Freilich, SE Hoffe, W Fulp, JM Weber, K Almhanna, ... Gastrointestinal cancer research: GCR 6 (2), 39, 2013 | 113 | 2013 |
| Beyond an updated graded prognostic assessment (breast GPA): a prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today PW Sperduto, S Mesko, J Li, D Cagney, A Aizer, NU Lin, E Nesbit, ... International Journal of Radiation Oncology* Biology* Physics 107 (2), 334-343, 2020 | 101 | 2020 |
| Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer SH Lin, KW Merrell, J Shen, V Verma, AM Correa, L Wang, PF Thall, ... Radiotherapy and Oncology 123 (3), 376-381, 2017 | 97 | 2017 |
| Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant … EA Mellon, WH Jin, JM Frakes, BA Centeno, TJ Strom, GM Springett, ... Acta Oncologica 56 (3), 391-397, 2017 | 78 | 2017 |
| Evidence-based review on the use of proton therapy in lymphoma from the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee YD Tseng, DJ Cutter, JP Plastaras, RR Parikh, O Cahlon, MD Chuong, ... International Journal of Radiation Oncology, Biology, Physics 99 (4), 825-842, 2017 | 77 | 2017 |
| Improving outcomes for esophageal cancer using proton beam therapy MD Chuong, CL Hallemeier, SK Jabbour, J Yu, S Badiyan, KW Merrell, ... International Journal of Radiation Oncology* Biology* Physics 95 (1), 488-497, 2016 | 73 | 2016 |
| Effect of primary tumor side on survival outcomes in untreated patients with metastatic colorectal cancer when selective internal radiation therapy is added to chemotherapy … P Gibbs, V Heinemann, NK Sharma, J Taieb, J Ricke, M Peeters, ... Clinical colorectal cancer 17 (4), e617-e629, 2018 | 67 | 2018 |
| Increased survival associated with surgery and radiation therapy in metastatic gastric cancer: a Surveillance, Epidemiology, and End Results database analysis R Shridhar, K Almhanna, SE Hoffe, W Fulp, J Weber, MD Chuong, ... Cancer 119 (9), 1636-1642, 2013 | 65 | 2013 |
| Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival PW Sperduto, S Mesko, J Li, D Cagney, A Aizer, NU Lin, E Nesbit, ... Neuro-oncology 22 (9), 1359-1367, 2020 | 58 | 2020 |
| Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with … EA Mellon, TJ Strom, SE Hoffe, JM Frakes, GM Springett, PJ Hodul, ... Journal of gastrointestinal oncology 7 (4), 547, 2016 | 54 | 2016 |
| Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy R Shridhar, SE Hoffe, K Almhanna, JM Weber, MD Chuong, RC Karl, ... Annals of surgical oncology 20, 3038-3043, 2013 | 53 | 2013 |
| Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer MD Chuong, JM Frakes, N Figura, SE Hoffe, R Shridhar, EA Mellon, ... Journal of gastrointestinal oncology 7 (2), 221, 2016 | 48 | 2016 |
